MDLZ vs NEO · P/E 30, rev $38.54B vs rev $388.3M
Mondelez International Inc (MDLZ) versus NeoGenomics Inc (NEO) — a side-by-side from cached financials, not a winner call.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Latest reported NEO revenue for 2026-06-30 was $388.3M. Net income was -$14.9M. NEO currently screens at market cap $924.0M.
MDLZ currently screens at market cap $78.12B and trailing P/E 30.1. NEO currently screens at market cap $924.0M.
Not investment advice. Open the MDLZ and NEO stock pages for the full models.
Not investment advice.